ARK Diagnostics, Inc. is committed to improving health care through the design, development, manufacture and distribution of in vitro diagnostic (IVD) immunoassays for therapeutic drug monitoring (TDM), urine drug testing (UDT) and other small molecules. Our focus is the production of high quality, convenient, cost-effective products for routine use in research and clinical practice.
ARK introduces its homogeneous enzyme immunoassay technology for the next generation of clinical laboratory testing.